Abstract:Accelerated decline in lung function contributes to the development of chronic respiratory disease. Despite evidence for a genetic component, few genetic associations with lung function decline have been identified. To evaluate genome-wide associations and putative downstream functionality of genetic variants with lung function decline in diverse general population cohorts. We conducted genome-wide association study (GWAS) analyses of decline in the forced expiratory volume in the first second (FEV ), forced vital capacity (FVC), and their ratio (FEV /FVC) in participants across six cohorts in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium and the UK Biobank. Genotypes were imputed to TOPMed (CHARGE cohorts) or Haplotype Reference Consortium (HRC) (UK Biobank) reference panels, and GWAS analyses used generalized estimating equation models with robust standard error. Models were stratified by cohort, ancestry, and sex, and adjusted for important lung function confounders and genotype principal components. Results were combined in cross-ancestry and ancestry-specific meta-analyses. Selected top variants were tested for replication in two independent COPD-enriched cohorts. Our discovery analyses included 52,056 self-reported White (N=44,988), Black (N=5,788), Hispanic (N=550), and Chinese American (N=730) participants with a mean of 2.3 spirometry measurements and 8.6 years of follow-up. Functional mapping of GWAS meta-analysis results identified 361 distinct genome-wide significant (p<5E-08) variants in one or more of the FEV , FVC, and FEV /FVC decline phenotypes, which overlapped with previously reported genetic signals for several related pulmonary traits. Of these, 8 variants, or 20.5% of the variant set available for replication testing, were nominally associated (p<0.05) with at least one decline phenotype in COPD-enriched cohorts (White [N=4,778] and Black [N=1,118]). Using the GWAS results, gene-level analysis implicated 38 genes, including eight (XIRP2, GRIN2D, SATB1, MARCHF4, SIPA1L2, ANO5, H2BC10, and FAF2) with consistent associations across ancestries or decline phenotypes. Annotation class analysis revealed significant enrichment of several regulatory processes for corticosteroid biosynthesis and metabolism. Drug repurposing analysis identified 43 approved compounds targeting eight of the implicated 38 genes. Our multi-ancestry GWAS meta-analyses identified numerous genetic loci associated with lung function decline. These findings contribute knowledge to the genetic architecture of lung function decline, provide evidence for a role of endogenous corticosteroids in the etiology of lung function decline, and identify drug targets that merit further study for potential repurposing to slow lung function decline and treat lung disease.

No Convincing Association Between Genetic Markers and Respiratory Symptoms: Results of a GWA Study

Multi-ancestry genome-wide association study reveals novel genetic signals for lung function decline

Shared genetic aetiology of respiratory diseases: a genome-wide multitraits association analysis

Genetic association of inflammatory marker GlycA with lung function and respiratory diseases

Genome-wide Association Studies for Identifying Genetic Architecture of SGRQ in Smoking Population

SNPs Identified by GWAS Affect Asthma Risk Through DNA Methylation and Expression of Cis-Genes in Nasal (airway) Epithelium

Genetic susceptibility to pneumonia: A GWAS meta-analysis between UK Biobank and FinnGen

Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease

Assessing the genetic relationship between gastroesophageal reflux disease and chronic respiratory diseases: a mendelian randomization study

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

Respiratory traits and coal workers’ pneumoconiosis: Mendelian randomisation and association analysis

Breathing new life into the study of COPD with genes identified from genome-wide association studies

GWAS reveals Genetic Susceptibility to Air Pollution-Related Asthma Exacerbations in Children of African Ancestry

Genetic overlap between impaired lung function and cardiovascular diseases revealed by a large-scale genome-wide cross-trait analysis

Genome-wide association study of susceptibility to hospitalised respiratory infections

A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity

Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets

Multi-ancestry Genome-Wide Association Analyses Improve Resolution of Genes and Pathways Influencing Lung Function and Chronic Obstructive Pulmonary Disease Risk

A Genome-Wide Gene-Environment Interaction Analysis for Tobacco Smoke and Lung Cancer Susceptibility.

Genome-Wide Association Analysis of Blood Biomarkers in Chronic Obstructive Pulmonary Disease